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a b s t r a c t
Coronary heart disease is the leading cause of death in the Czech Republic. Pathological data
have shown that atherosclerosis begins in childhood and that the extent of atherosclerosis
in children can be correlated with the presence of cardiovascular risk factors such as:
hypercholesterolemia,  obesity, hypertension and cigarette smoking. Pediatric preventive
program in the Czech Republic, which started in 1992, identiﬁes children at high risk of
atherosclerosis.  At the age of 5 and 13 years, pediatricians are obliged to measure not only
blood pressure and BMI, but also lipid proﬁle (plasma total cholesterol, LDL, HDL cholesterol
and triglycerides) in children with positive family history. This obligation is incorporated in
the health certiﬁcate of everyone born in the Czech Republic. The lipoprotein proﬁling is also
offered to other family members. Children identiﬁed as being at an increased risk of
ischemic heart disease are referred to pediatric cardiologists or specialized centers to be
followed up and treated. During the past two decades this strategy has promoted cardio-
vascular health for all children and contributed signiﬁcantly to progress in the reduction of
mortality for cardiovascular diseases in the Czech Republic.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z  o.o.
All rights reserved.
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Lipoprotein Values
Acceptable Marginal Pathologic
Total cholesterol <4.4 4.4–5.0 >5.0
LDL cholesterol <2.9 2.9–3.3 >3.3
HDL cholesterol >1.2 1.0–1.2 <1.0
Triglycerides <1.0 1.0–1.5 >1.5
Table 2 – Criteria for pharmacological treatment of
familial hypercholesterolemia in children.
Total cholesterol 8 mmol/l
LDL cholesterol 4.9 mmol/l
LDL cholesterol 4.1 mmol/l + positive family history
2 risk factors (high triglycerides, low HDL, obesity, smoking,
hypertension)Introduction
Manifest myocardial infarction and stroke in children is rare,
but risk factors of cardiovascular disease begin in childhood.
Vsevolod A. Zinserling was the ﬁrst to show already in 1924
that the fatty streaks are present in arteries of children. He
described that the fatty streaks contain cholesterol and are
precursors of atherosclerosis [1]. His ﬁnding was veriﬁed in
1953 in Korean war casualties [2] and later in the Pathobio-
logical Determinants of Atherosclerosis in Youth (PDAY) study
[3] and the Bogalusa Heart Study [4]. Both the presence and
extent of atherosclerotic lesions at autopsy after unexpected
deaths in children correlate with established risk factors:
namely high cholesterol, high blood pressure, elevated body
mass index, and evidence of cigarette smoking. This is why the
prevention of coronary heart disease logically started moving
to childhood [5].
Beginning of prevention of atherosclerosis from
childhood in the Czech Republic
The prevention of coronary heart disease from childhood was
ofﬁcially launched in the Czech Republic in 1992 (Ministry of
Health Decree No. 56/1992 Coll.). The decree imposes general
practitioners for children to include a preventive examination
in children from high-risk families for dyslipidemia; this
examination is carried out for each child in 5 and 13 years, to
search in children from high-risk families for dyslipidemia. All
the information is recorded in the health certiﬁcate, which has
each child. Children, in which the ﬁndings are proved and are
beyond the practical capabilities of the children's doctor, are
then sent to the relevant professionals where the lipoprotein
proﬁling is offered also to other members of the family. A
signiﬁcant number of parents at high risk for coronary heart
disease can be identiﬁed through their children. More than
2000 general practitioners for children and adolescents, 150
specialized pediatric cardiologists, obesitologists and diabe-
tologists as well as other professions like nutritionists and
physical therapeutists are engaged in the prevention of
coronary heart disease [6].
It is of paramount importance to carefully evaluate family
history at each checkup. Doctors are searching for coronary
death or disease, stroke, peripheral vascular disease, diabetes
mellitus in fathers younger than 55 years or mothers under the
age of 65, but also in grandparents and other close relatives.
Also included in a positive family history is the presence of
obesity, severe hypertension and increased levels of total
cholesterol in parents (6.0 mmol/l). When a positive family
history is determined, or if there are present signiﬁcant risk
factors of the child, the total HDL cholesterol and triglyceride
levels are measured after overnight fasting [7].
Dyslipidemia
Dyslipidemia belongs to the most severe but easily detectable
risk factors of atherosclerosis. Young adults with an increased
level of total cholesterol (>5.2 mmol/l) had ﬁve times therisk of developing cardiovascular disease 40 years later
compared with those who had a total cholesterol level lower
(<3.1 mmol/l) [8].
Children with pathological levels of non-HDL cholesterol,
increased LDL or total cholesterol should be sent in our country
to the pediatric cardiologist or lipidologist. In children with
familial hypercholesterolemia it is recommended to start after
two years of age with an adjustment of diet. For other children
with persistent but not familial hypercholesterolemia diet
starts from 5 years of age. Pharmaceutical treatment of a child
should always be carefully decided by a pediatric lipidologist or
cardiologist. Of the current pharmacological treatment
options for children, it should be referred only to the treatment
with statins. Previously, the only recommended medication
for a child was resins, which are currently difﬁcult to obtain,
have a bad taste and have low adherence. Fibrates are
contraindicated in children due to their side effects and
Ezetrol is used in monotherapy in children only if they cannot
be treated with statins.
When considering to start pharmacological treatment, it
should be realized that this treatment is usually long lasting
and often throughout the child's lifetime. Therefore, we
always have to consider whether the risk of hypolipidemic
therapy is not greater than its beneﬁts. Usually pharmaco-
therapy is started only in children aged 8–10 years with a very
serious family history of hypercholesterolemia, when the total
cholesterolemia did not fall after 6–12 months of non-
pharmacological treatment under 8.0 mmol/l, if the value of
LDL cholesterol did not fall below 4, 9 mmol/l, or when
hypecholesterolemia occurs in a child who has two or more
risk factors (Table 1).
In 1997 we tried to ﬁnd the value of total cholesterol in
Czech children [9]. In examinations of 1378 children and
adolescents aged 1–17 years (707 boys and 671 girls) from
different regions of the Czech Republic, we found that 60% of
children aged 7–13 years had an increased total cholesterol
over 4.4 mmol/l. In total, 26% of them already belonged to the
‘‘high risk’’ category with the level of total cholesterol above
5.2 mmol/l. Normal and pathological values of lipids and
children's age are laid down in Table 2. These values are
Table 4 – Overweight and obesity measured in 7427 Czech
children in 2006.
Age (years) Overweight Obesity
Boys
5 2.0% 3.0%
13 2.2% 5.4%
18 0.9% 3.0%
Girls
5 1.0% 4.3%
13 3.0% 5.9%
18 1.2% 3.0%
Table 5 – Classification of hypertension in children.
Systolic (SBP) or diastolic
blood pressure (DBP)
Percentilea
Normal <90th
High normal 90 to <95
or if BP exceeds 120/80 mmHgb
Stage 1 hypertension 95th to 99th plus 5 mmHg
Stage 2 hypertension >99th plus 5 mmHg
a For gender, age, and height measured on at least 3 separate
occasions
b This occurs typically at 12 years old for SBP and at 16 years old for
DBP.
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levels was demonstrated in the United States. Just over a
decade lipid levels in the pediatric population had increased
signiﬁcantly. In the Lipid Research Clinics Prevalence Study
from 1970 to 1976 in children aged 0–19 years the mean total
cholesterol level was 4.1 mmol/l, with the 95th percentile of
5.1 mmol/l [10]. The NHANES III collected cholesterol levels in
more than 7000 U.S. children ages 0–19 years from 1988 to 1994.
The mean total cholesterol level was 4.4 mmol/l, and the 95th
percentile was 5.5 mmol/l [11].
Overweight and obesity in children
Epidemiological studies show that being overweight and obese
during childhood are among the most serious and underlying
risk factors for premature atherosclerosis and coronary
disease in adult life [12]. About three-quarters of children
with obesity continue to have obesity into adulthood.
The recent Expert Panel on Integrated Guidelines for
Cardiovascular Health and Risk Reduction in Children and
Adolescents recommends that children and adolescents ages
2–18 years with a BMI at or greater than the 95th percentile be
described as ‘‘obese’’. For children with a BMI between the 85th
and 95th percentiles, the term ‘‘overweight’’ should be used
[13]. Our criterion for overweight was selected as 90th to 97th
percentile of BMI and obese children were considered those at
97th percentile and higher.
Incidence of being overweight and obese on All-state
Anthropological Investigation of Children and Youth in the
Czech Republic carried out in 1991 and in 2001 in the Czech
Republic has shown that the obesity proportions are below
those detected in a number of other developed countries
[14,15] (Table 3). The further investigation of prevalence of
overweight and obesity in the Czech Republic was performed
in 2006 by 57 physicians in a total of 7427 children (51% of boys)
since birth till their 18 years of age. The examination was made
at the age categories of 5, 13 and 18 years. These measure-
ments showed results similar to those measured in the year
1991 and 2001 on All-state Anthropological Investigation.
Overweight was established in 1.8% and obesity in 4.2% of
children. Obesity is most commonly observed in boys and girls
at the age of 13 while the incidence of obesity declines after the
age of 18. A similar trend can also be found in overweight
children (Table 4) [16].Table 3 – Overweight and obesity among Czech children
in 1991 and 2001.
1991 2001
Boys
Overweight 7.0% 7.1%
Obesity 3.0% 6.0%
Total 10.0% 13.1%
Girls
Overweight 7.0% 6.3%
Obesity 3.0% 5.6%
Total 10.0% 11.9%Hypertension
High blood pressure is a major risk factor for coronary heart
disease, stroke and peripheral vascular disease. A meta-
analysis of 50 cohort studies conﬁrmed that blood pressure
tracks from childhood into adulthood [17]. Adults with
elevated blood pressure from childhood had increased risk
of atherosclerosis [18].
Blood pressure rises with the age of the child and is also
determined by gender, body height and weight. Therefore,
blood pressure in children should not be classiﬁed by body
mass index as in adulthood but by using percentiles. We are
using the classiﬁcation of hypertension listed in a table
(Table 5) [19]. For practical reasons there is used the height of a
child at the relevant age for assessment of blood pressure in
the table which shows the highest normal values (Table 6) [20].Table 6 – The upper limit of normal blood pressure,
depending on the age and height of the characters.
Age (years) Girls Boys
Percentiles of
height
Percentiles of
height
50th 75th 50th 75th
1 104/58 105/59 103/56 104/58
6 111/74 113/74 111/74 115/75
12 128/80 124/81 123/81 125/82
17 129/81 130/85 136/87 137/87
Table 7 – Hypertension in obese children in the Czech
Republic.
Age (years) Normal weight Overweight Obesity
5 44% 50% 6%
13 12% 16% 72%
18 43% 7% 50%
Total 30% 17% 53%
Table 8 – The prevalence of smoking among children in
the Czech Republic.
Age (years) 1994 1998 2002
11 1.9% 1.4% 2.0%
13 5.8% 8.6% 11.1%
15 13.9% 19.9% 29.7%
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were obtained from 7427 children across the Czech Republic.
Hypertension (above 95 percentile) was diagnosed in 115 (1.54)
of the 7427 children examined, being present more often in
boys than in girls (1.02% vs. 0.52%). In the 5-year-old,
hypertension was present in only 0.86%, in the 15-year-old
in 1.88%, and in the 18-year-old in 1.75%. Hypertension was
predominating in boys at all ages [21].
Prevalence of hypertension increases in parallel with
childhood obesity [22]. Hypertension was more common
among overweight and obese children also in our study. Up
to 72% of children with hypertension were obese at the age of
13. About the same trend was demonstrated also at a later age
(Table 7) [21].
Smoking
Smoking, particularly cigarette smoking, is a major risk factor
that leads to vascular dysfunction and coronary disease. The
evidence that smoking is harmful is unequivocal [23].
Moreover, involuntary tobacco smoke exposure by second-
hand smoke, impair the health of fetuses, infants, children and
adolescents [24]. The goal of clinical intervention is complete
cessation of tobacco use.
Children have been observed to start with smoking in the
Czech Republic at the age of 11. By 13 years, 11.1% of children
are regularly smoking and by 15 years of age, 29.7% of children
(Table 8) [25]. The prevalence of smoking at all ages was found
to have increased, in 13-year-olds from 5.8% in 1994 to 11.1% in
2002, and in 15-year-olds from 13.9% in 1994 to 29.7% in 2002.
The prevalence of smoking in girls reached in 2002 even higher
value than in boys. This trend was ﬁnished in 2006 and the
prevalence of regular smokers decreased to 15% in boys and to
18% in girls.
Conclusion
The aims of prevention of coronary heart disease from
childhood is to check the development of all risk factors
(obesity, hypercholesterolemia, hypertension), to teach chil-
dren a healthy lifestyle, include regular physical activities, deterthem from smoking, and to optimize lipid levels and blood
pressure individually with appropriate treatment in adulthood.
In conclusion, it can be stated that the twenty years of
preventive medicine starting from childhood has contributed
signiﬁcantly to the progress in reduction of mortality from
cardiovascular diseases in the Czech Republic.
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